D
Company Profile
DropGenie
DropGenie develops digital microfluidic chips that automate laboratory tasks for pharmaceutical and life sciences researchers.
1
Dispatches
Oct 26, 2026
Latest story
Editorial lens
Why Boreal Signal tracks this company
We track DropGenie to understand how its decisions in digital microfluidic gene editing affect the market and its Canadian operations.
Profile facts
- Coverage focus
- Digital microfluidic gene editing
- Related stories
- 1
- Last reviewed
- Oct 26, 2026
Profiles are based on Boreal Signal reporting and are updated as new stories are published.
All stories about this company
Montréal’s DropGenie raises US$5 million to commercialize a gene-editing chip
Montréal’s DropGenie raises US$5 million to commercialize a gene-editing chip
The company says its chip can use up to 100 times fewer cells and less reagent than traditional tests; BetaKit’s report provides no independent comparison of those claimed savings.
Read article